0001179110-16-022870.txt : 20160406
0001179110-16-022870.hdr.sgml : 20160406
20160406182338
ACCESSION NUMBER: 0001179110-16-022870
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160404
FILED AS OF DATE: 20160406
DATE AS OF CHANGE: 20160406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001034842
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943248524
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
MAIL ADDRESS:
STREET 1: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maynard Ryan D
CENTRAL INDEX KEY: 0001363984
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29889
FILM NUMBER: 161558498
MAIL ADDRESS:
STREET 1: RIGEL PHARMACEUTICALS, INC.
STREET 2: 1180 VETERANS BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgar.xml
FORM 4 -
X0306
4
2016-04-04
0
0001034842
RIGEL PHARMACEUTICALS INC
RIGL
0001363984
Maynard Ryan D
RIGEL PHARMACEUTICALS, INC.
1180 VETERANS BLVD.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
EVP & CFO
Employee Stock Option (right to buy)
3.59
2016-04-04
4
A
0
62500
0
A
2024-02-27
Common Stock
62500
62500
D
Employee Stock Option (right to buy)
2.14
2016-04-04
4
A
0
175000
0
A
2025-01-26
Common Stock
175000
175000
D
On February 27, 2014, the reporting person was granted an option to purchase 62,500 shares of common stock. The option vests based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On April 4, 2016, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option.
On January 26, 2015, the reporting person was granted an option to purchase 175,000 shares of common stock. The option vests based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On April 4, 2016, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option.
/s/ Dolly Vance (Attorney-in-Fact)
2016-04-06